Copy to clipboard 
Oxford Performance Materials (OPM) entered into an agreement with VySpine to develop a new spinal implant product line utilizing OPM’s patented OsteoFab® PEKK technology.
The agreement between the companies enables VySpine to develop new interbody devices and other spinal implants featuring OPM’s proprietary 3D printing IP, delivering benefits such as bone-like mechanics, bone ongrowth, radiolucency and antibacterial/antiviral properties, all produced with OPM’s (metal and metallosis-free) OXPEKK® material formulation.
“We are delighted to be making this important announcement with VySpine,” said OPM founder & CEO Scott DeFelice. “OPM has a history of developing industry partnerships with companies dedicated to innovative solutions that push medical device technology forward in ways that improve patient outcomes. VySpine clearly fits that mold.”
